The Total Pancreatectomy and Auto Islet Transplantation Program offers a procedure for patients with acute recurrent and chronic pancreatitis who have chronic severe abdominal pain and who do not respond to conventional treatment.
In the first part of the double procedure, the pancreas is surgically removed (called a total pancreatectomy). In the second part of the procedure, auto islets (insulin-producing cells found in the pancreas) are removed from the pancreas and transplanted to the liver.
The pancreatectomy relieves pain while the auto islet transplantation reduces the need for insulin, which would otherwise be necessary for people without a pancreas.
Benefits of Pancreatectomy and Auto Islet Transplantation
Approximately 80 percent of patients experience significant reduction, if not resolution, of pain after the pancreas is removed. Over time, some patients may become diabetic and need insulin.
Having this surgery done at Johns Hopkins provides patients with the reassurance that a surgeon who specializes in pancreatic surgery and auto islet transplantation will be doing the procedure, assisted by a team of other doctors and nurses who are also specialists.
Patients who are candidates for this procedure will be treated by a multidisciplinary team that will look at every aspect of the patient’s health and lifestyle to make sure that procedure will offer the patient the most benefit and the least risk.
Program Faculty and Staff
Vikesh K. Singh, M.D., M.Sc., Medical Director
Islet Cell Laboratory
Michael Shamblott, Ph.D., Director
Rita Kalyani, M.D.
Erica Hall, CRNP
Asad Latif, M.D.